INNOCARE(688428) 证券之星·2025-05-16 09:33Core Viewpoint - The company, Innocare Pharma, is holding an investor briefing on May 26, 2025, to discuss its Q1 2025 financial results and operational performance [1][2]. Group 1: Meeting Details - The investor briefing is scheduled for May 26, 2025, from 9:00 AM to 10:00 AM [2]. - The meeting will take place at the Shanghai Stock Exchange Roadshow Center, accessible via the website: http://roadshow.sseinfo.com/ [2]. - The format of the meeting will be an online interactive session [1][2]. Group 2: Participation Information - Investors can submit questions from May 19, 2025, to May 23, 2025, by visiting the Roadshow Center's website or emailing IR@innocarepharma.com [1][3]. - The company will address commonly asked questions during the briefing [1][3]. Group 3: Attendees - Key attendees include Dr. Jisong Cui (Chairman and CEO), Ms. Hulan (Independent Non-Executive Director), Mr. Fu Xin (CFO), and Ms. Yuan Bei (Domestic Information Disclosure Representative) [2].